# Effect of Body-mass Index (BMI) on Median Effective Dose of Intrathecal Hyperbaric Bupivacaine

> **NCT01291186** · NA · COMPLETED · sponsor: **Seoul Medical Center** · enrollment: 108 (actual)

## Conditions studied

- Arthroplasty, Knee

## Interventions

- **DRUG:** BPV6NO
- **DRUG:** BPV7NO
- **DRUG:** BPV8NO
- **DRUG:** BPV9NO
- **DRUG:** BPV10NO
- **DRUG:** BPV11NO
- **DRUG:** BPV6O
- **DRUG:** BPV7O
- **DRUG:** BPV8O
- **DRUG:** BPV9O
- **DRUG:** BPV10O
- **DRUG:** BPV11O

## Key facts

- **NCT ID:** NCT01291186
- **Lead sponsor:** Seoul Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2011-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291186, "Effect of Body-mass Index (BMI) on Median Effective Dose of Intrathecal Hyperbaric Bupivacaine". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01291186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*